Quick Answer
Anbio Biotechnology reported Research And Development Expense of $454.2 thousand for the year ending 2024.
- Anbio Biotechnology showed an increase of +237.2% in Research And Development Expense from 2023 to 2024.
- This data is from Anbio Biotechnology's annual report (Form 10-K), filed with the SEC on April 28, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2022 to 2024), Anbio Biotechnology's Research And Development Expense has grown by 127.1%.
- Historical annual values: Fiscal year 2024: $454.2 thousand | Fiscal year 2023: $134.7 thousand | Fiscal year 2022: $200.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: